Pfizer
PFE
$0.48 (1.91%)
1D
1W
3M
1Y
5Y
ALL
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
24/7 Wall Street • 2 hours ago • PFE
Baby Boomers Hit the Passive Income Lottery With 5 Blue-Chip Dividend StocksSeeking Alpha • 1 day ago • PFE
Pfizer: High Dividend And Low Price Might Still Offset The Expanding RisksZacks Investment Research • 1 day ago • PFE
PFE vs. NVO: Which Stock Is the Better Value Option?Zacks Investment Research • 1 day ago • PFE
5 Best Value Stocks With Discounted PEG to Boost Your Portfolio ReturnZacks Investment Research • 1 day ago • PFE
Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EUCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.